ICU Medical ICUI Government Grant Revenue — Revenue, Remaining Performance Obligation, Amount
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by ICU Medical in its filing.
Tagged under the XBRL concept us-gaap:RevenueRemainingPerformanceObligation.
The official record: ICU Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ICU Medical's government grant revenue — revenue, remaining performance obligation, amount.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ICU Medical's government grant revenue — revenue, remaining performance obligation, amount?
- ICU Medical (ICUI) reported government grant revenue — revenue, remaining performance obligation, amount of $4.77M in Q1 2026.
- How has ICU Medical's government grant revenue — revenue, remaining performance obligation, amount changed year-over-year?
- ICU Medical's government grant revenue — revenue, remaining performance obligation, amount decreased by 30.2% year-over-year, from $6.83M to $4.77M.
- What is the long-term trend for ICU Medical's government grant revenue — revenue, remaining performance obligation, amount?
- Over 3 years (2022 to 2025), ICU Medical's government grant revenue — revenue, remaining performance obligation, amount has grown at a -22.9% compound annual growth rate (CAGR), from $52.9M to $24.23M.
- What does government grant revenue — revenue, remaining performance obligation, amount mean?
- This metric quantifies the total transaction price allocated to government grant performance obligations that are unsatisfied or partially unsatisfied as of the reporting date. It provides visibility into the future revenue expected to be recognized as the company fulfills its contractual or regulatory obligations tied to government funding. Investors use this to assess the durability and future revenue visibility of the company's grant-funded initiatives.